Apr 27, 2022
The promise of angel-scale biotech: Learn More
Founder & VC Aaron Michel of 1984.vc on portfolio companies, Reggora, Faimarkit and Relevize and how they exemplify the firm’s approach to seed-stage investing. Aaron also gives Sal a mind-expanding suggestion on angel-scale biotech. Compelling & jargon-free!
Sponsored by Purdue University entrepreneurship and Peter Fasse, patent attorney at Fish & Richardson
- Sal Daher, CFA Introduces Aaron Michel, Venture Capitalist at 1984.VC
- Reggora: “...they're just enabling the lenders to do an appraisal almost in an Uberized fashion, in a much faster and much more efficient way than it used to be.”
- Brian & Will of Reggora Sold $5 Million of Real Estate in their Senior Year at Boston University
- A Dorm Room Business Helped the Founders of Reggora Discover a Scalable Business Opportunity
- Fairmarkit Is Automating the Enterprise Procurement Process
- Relevize – Helps Companies Sell Better via Channel Partners
- Relevize Gives Channel Partners Digital Advertising Content and Then Monitors Performance
- Aaron Michels Founded PathSource to Help People Find the Right Career
- Sal’s Partner Bob Smith Was Not Cut Out for the Law But was a Natural Entrepreneur
- “Both my parents are professors. They were both professors at Boston University. Both had started companies.”
- CareerPath’s Pivot
- How Aaron Michel Crossed Over from Being an Operator to Being a VC
- “Ideally, you can choose your competitor set.”
- “For B2B actually, we are open to investing pre-launch, as long as there's a product.”
- Aaron Michel’s Mind-Expanding Suggestion for How Better to Address the Opportunities of Angel-Scale Biotech
- “VCs tend to overvalue their advice and undervalue their introductions.”
Topics: founding story, competition, venture capital